Condition
NSCLC Stage II clinical trials and research
As of November 12, 2026, Find a Trial lists 5 NSCLC Stage II clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (1), Germany (1)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest NSCLC Stage II clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adaptive Chemotherapy for PD-L1 High Resectable NSCLC: A Chemo-PHREE Trial | Phase 2 | Indianapolis, Indiana and 4 other locations | Recruiting | Aug 5, 2026 |
| Anti-CTLA-4 plus sintilimab and chemotherapy before surgery for resectable Stage II–III NSCLC | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Feb 13, 2026 |
| BIO 300 with thoracic radiation for early-stage non-small cell lung cancer and interstitial lung disease | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Jan 7, 2026 |
| Pilot Precision Exercise Program for Lung Cancer Care | — | Galveston, Texas and 1 other locations | Recruiting | Apr 25, 2025 |
| Predicting response to immunotherapy and chemotherapy in lung cancer | Phase 2 | Heidelberg, BaWü | Recruiting | Apr 29, 2021 |
All recruiting trials (5)
-
Adaptive Chemotherapy for PD-L1 High Resectable NSCLC: A Chemo-PHREE Trial
This study tests cemiplimab in adults with resectable non-small cell lung cancer to see if surgery can be pursued without preceding chemotherapy for some patients.
-
Anti-CTLA-4 plus sintilimab and chemotherapy before surgery for resectable Stage II–III NSCLC
This trial will test whether adding an anti-CTLA-4 antibody (IBI310) to sintilimab plus chemotherapy before surgery helps people with PD-L1–negative, resectable Stage II–III non-small cell lung cancer.
-
BIO 300 with thoracic radiation for early-stage non-small cell lung cancer and interstitial lung disease
This trial will test whether adding BIO 300 to thoracic radiation lowers the chance of pneumonitis in people with stage I–II non-small cell lung cancer who also have interstitial lung disease.
-
Pilot Precision Exercise Program for Lung Cancer Care
This pilot will test whether a personalized, virtually supervised home exercise program delivered by telehealth can be implemented and helpful for people with stage II-III non-small cell lung cancer who are receiving chemotherapy or immunotherapy plus surgery.
-
Predicting response to immunotherapy and chemotherapy in lung cancer
This study is testing if a special immune profile can help predict how well patients with lung cancer will respond to a combination of treatments before surgery.
Related topics
Quick answers
How many NSCLC Stage II clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.